Elevated intraocular force has become the diagnostic criteria for glaucoma, and reducing intraocular force is really a target of glaucoma therapies (Prum et al., 2016). The trial was evaluated as “unclear” threat of bias. No variances in intraocular force had been found in between placebo and cannabinoids. It is possible https://carcrashcompensation24630.tinyblogging.com/an-unbiased-view-of-cannabinoids-76570405